TY - JOUR
T1 - Interaction of Factor XII and high molecular weight kininogen with cytokeratin 1 and gC1qR of vascular endothelial cells and with aggregated Aβ protein of Alzheimer's disease
AU - Joseph, Kusumam
AU - Shibayama, Yoji
AU - Nakazawa, Yoshitaka
AU - Peerschke, Ellinor I.B.
AU - Ghebrehiwet, Berhane
AU - Kaplan, Allen P.
PY - 1999/9
Y1 - 1999/9
N2 - High molecular weight kininogen (HK) attaches to endothelial cells at separate sites on the heavy and light chains by a process which requires 15-50 μM zinc. Previously identified binding proteins include gC1qR, cytokeratin 1, and the urokinase plasminogen activator receptor (U-par), however, their relative contribution to binding are not yet clarified. We have purified the binding proteins by affinity chromatography, in the presence of zinc ion, and identified cytokeratin 1 and gC1qR by amino acid sequencing of an internal peptide and by immunoblot as heavy chain and light chain binding proteins, respectively. Antibody to cytokeratin 1 inhibited HK binding to endothelial cells by 30%, antibody to gC1qR inhibited HK binding to endothelial cells by 72%, and a mixture of both inhibited binding by 86%. The binding and activation of the proteins of the kinin-forming cascade along the cell surface is zinc-dependent. Similarly, proteins of the plasma kinin-forming cascade can be activated by binding to aggregated Aβ protein of Alzheimer's disease. Activation of the cascade using purified proteins or upon addition of Aβ to plasma requires aggregation of Aβ and the reactions are zinc-dependent. In plasma, HK is cleaved and bradykinin is liberated. The data demonstrate that aggregated Aβ can bind and activate proenzymes of the plasma kinin-forming cascade to release bradykinin and these reactions are dependent on zinc ion. Copyright (C) 1999 Elsevier Science B.V.
AB - High molecular weight kininogen (HK) attaches to endothelial cells at separate sites on the heavy and light chains by a process which requires 15-50 μM zinc. Previously identified binding proteins include gC1qR, cytokeratin 1, and the urokinase plasminogen activator receptor (U-par), however, their relative contribution to binding are not yet clarified. We have purified the binding proteins by affinity chromatography, in the presence of zinc ion, and identified cytokeratin 1 and gC1qR by amino acid sequencing of an internal peptide and by immunoblot as heavy chain and light chain binding proteins, respectively. Antibody to cytokeratin 1 inhibited HK binding to endothelial cells by 30%, antibody to gC1qR inhibited HK binding to endothelial cells by 72%, and a mixture of both inhibited binding by 86%. The binding and activation of the proteins of the kinin-forming cascade along the cell surface is zinc-dependent. Similarly, proteins of the plasma kinin-forming cascade can be activated by binding to aggregated Aβ protein of Alzheimer's disease. Activation of the cascade using purified proteins or upon addition of Aβ to plasma requires aggregation of Aβ and the reactions are zinc-dependent. In plasma, HK is cleaved and bradykinin is liberated. The data demonstrate that aggregated Aβ can bind and activate proenzymes of the plasma kinin-forming cascade to release bradykinin and these reactions are dependent on zinc ion. Copyright (C) 1999 Elsevier Science B.V.
KW - Alzheimer's disease
KW - Factor XII
KW - Kininogen
UR - https://www.scopus.com/pages/publications/0032755652
U2 - 10.1016/S0162-3109(99)00136-8
DO - 10.1016/S0162-3109(99)00136-8
M3 - Article
C2 - 10596854
AN - SCOPUS:0032755652
SN - 0162-3109
VL - 43
SP - 203
EP - 210
JO - Immunopharmacology
JF - Immunopharmacology
IS - 2-3
ER -